Protein-losing enteropathy associated with arsenic poisoning.
D000284:Administration, Oral; D001151:Arsenic / Q000008:administration & dosage / Q000009:adverse effects / Q000032:analysis; D020261:Arsenic Poisoning; D001706:Biopsy; D002648:Child; D004112:Dimercaprol / Q000627:therapeutic use; D004487:Edema / Q000139:chemically induced; D005260:Female; D006197:Hair / Q000032:analysis; D006801:Humans; D007019:Hypoproteinemia / Q000139:chemically induced; D007583:Jejunum / Q000473:pathology; D011041:Poisoning / Q000188:drug therapy; D011504:Protein-Losing Enteropathies / Q000139:chemically induced* / Q000473:pathology
D004112:Dimercaprol; D001151:Arsenic